METFIG L 5/1000 (Metformin (1000mg) + Linagliptin (5mg))

METFIG-L 5/1000mg Tablet is a medicinal formulation that comprises two active ingredients aimed at managing elevated blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This medication functions by enhancing the body’s insulin sensitivity and decreasing glucose synthesis in the liver, thereby aiding in the regulation of blood sugar. It may be prescribed as a standalone treatment or in conjunction with other antidiabetic medications. To maximize its efficacy, it should be utilized alongside a balanced diet and consistent physical activity. The prescribed dosage of METFIG-L 5/1000mg Tablet will vary based on the individual’s health status, blood glucose readings, and any additional medications being utilized. For optimal results and to mitigate gastrointestinal discomfort, it is advisable to take the tablet with food. Adherence to the prescribed regimen is critical; patients should avoid altering their dosage or discontinuing use without consulting their healthcare provider. Maintaining recommended dietary habits and exercise routines is essential in effectively managing diabetes. The medication may lead to common side effects such as headaches, feelings of nausea, dizziness, and skin rashes. Additionally, there is a potential risk of low blood sugar levels, particularly if taken with other diabetes medications like insulin or sulfonylureas. Should any side effects become persistent or aggravating, patients are encouraged to seek medical advice. Prior to commencing treatment with METFIG-L 5/1000mg Tablet, it is important to disclose any history of renal, hepatic, or cardiovascular conditions or pancreatic issues to the prescribing physician. Pregnant or nursing individuals should also seek guidance from their healthcare provider regarding the use of this medication.